XENE

Xenon Pharmaceuticals (XENE)

About Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Details

Daily high
$57.47
Daily low
$55.73
Price at open
$56.13
52 Week High
$63.95
52 Week Low
$28.19
Market cap
5.4B
Dividend yield
0.00%
Volume
920,547
Avg. volume
920,931
P/E ratio
-12.00

Xenon Pharmaceuticals News

Details

Daily high
$57.47
Daily low
$55.73
Price at open
$56.13
52 Week High
$63.95
52 Week Low
$28.19
Market cap
5.4B
Dividend yield
0.00%
Volume
920,547
Avg. volume
920,931
P/E ratio
-12.00